Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$161.01 - $317.85 $12.6 Million - $24.9 Million
78,291 Added 37.51%
287,037 $90.9 Million
Q2 2023

Aug 14, 2023

SELL
$176.32 - $240.22 $6.16 Million - $8.39 Million
-34,929 Reduced 14.33%
208,746 $45.3 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $12.8 Million - $16.2 Million
79,060 Added 48.03%
243,675 $44.3 Million
Q4 2022

Feb 14, 2023

SELL
$191.53 - $236.82 $325,792 - $402,830
-1,701 Reduced 1.02%
164,615 $32.3 Million
Q3 2022

Nov 14, 2022

BUY
$123.79 - $277.42 $5.02 Million - $11.2 Million
40,523 Added 32.21%
166,316 $37.4 Million
Q2 2022

Aug 12, 2022

BUY
$93.97 - $143.33 $838,588 - $1.28 Million
8,924 Added 7.64%
125,793 $15.9 Million
Q1 2022

May 13, 2022

SELL
$98.9 - $132.37 $16.3 Million - $21.8 Million
-164,832 Reduced 58.51%
116,869 $14.8 Million
Q4 2021

Feb 14, 2022

BUY
$110.64 - $159.4 $670,146 - $965,485
6,057 Added 2.2%
281,701 $36.9 Million
Q3 2021

Nov 12, 2021

BUY
$101.2 - $125.87 $87,436 - $108,751
864 Added 0.31%
275,644 $33.7 Million
Q2 2021

Aug 13, 2021

BUY
$107.45 - $135.95 $1.75 Million - $2.21 Million
16,280 Added 6.3%
274,780 $31.3 Million
Q1 2021

May 17, 2021

BUY
$95.46 - $133.08 $11.6 Million - $16.1 Million
121,100 Added 88.14%
258,500 $31.1 Million
Q4 2020

Feb 16, 2021

BUY
$75.23 - $109.23 $692,116 - $1 Million
9,200 Added 7.18%
137,400 $14 Million
Q3 2020

Nov 13, 2020

BUY
$71.31 - $109.74 $9.14 Million - $14.1 Million
128,200 New
128,200 $9.91 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.